Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 51 | 0 | 7 | 0 | 722,00 € | 766,92 € | 6,22 % |
| Boston Scientific | 46 | 0 | 13 | 0 | 67,00 € | 72,96 € | 8,89 % |
| Biogen Inc. | 44 | 2 | 4 | 1 | 201,10 € | 293,57 € | 45,98 % |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | 377,85 € | 382,71 € | 1,28 % |
| Intuitive Surgical Inc | 34 | 0 | 4 | 0 | 349,95 € | 370,00 € | 5,73 % |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 7 | 1 | 849,60 € | 957,22 € | 12,67 % |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | 452,95 € | 543,72 € | 20,04 % |
| Thermo Fisher Scientific Inc. | 27 | 0 | 6 | 0 | 540,80 € | 568,09 € | 5,05 % |
| Tenet Healthcare | 27 | 0 | 6 | 0 | 109,00 € | 101,06 € | -7,28 % |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | 121,00 € | 124,93 € | 3,25 % |
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | 78,60 € | 87,48 € | 11,29 % |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | 59,50 € | 81,53 € | 37,02 % |
| Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | 68,50 € | 79,43 € | 15,96 % |
| Humana Inc. | 23 | 0 | 6 | 0 | 295,20 € | 439,88 € | 49,01 % |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | 134,15 € | 137,63 € | 2,60 % |
| HCA Holdings Inc. | 22 | 0 | 6 | 0 | 290,10 € | 295,60 € | 1,89 % |
| Stryker Corp. | 22 | 0 | 9 | 0 | 309,50 € | 334,89 € | 8,20 % |
| Trinity Biotech ADR | 22 | 0 | 1 | 0 | 0,41 € | - | - |
| Amgen Inc. | 21 | 0 | 3 | 0 | 261,10 € | 294,28 € | 12,71 % |
| Zoetis Inc. A | 21 | 1 | 4 | 1 | 152,68 € | 200,06 € | 31,03 % |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | 77,98 € | 102,62 € | 31,60 % |
| AbbVie Inc. | 20 | 1 | 3 | 1 | 152,04 € | 174,43 € | 14,73 % |
| R1 RCM Inc. | 19 | 0 | 2 | 0 | 11,40 € | 17,21 € | 50,99 % |
| Resmed Inc. | 19 | 0 | 3 | 0 | 199,20 € | 207,72 € | 4,27 % |
| Dexcom Inc. | 18 | 0 | 3 | 0 | 119,06 € | 136,82 € | 14,92 % |